You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Details for Patent: 10,463,624


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,463,624
Title:Controlled release formulations
Abstract: The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.
Inventor(s): Krishnamurthy; Thinnayam N. (Scarborough, CA), Darke; Andrew (Newmarket, CA)
Assignee: RHODES PHARMACEUTICALS L.P. (Coventry, RI)
Application Number:15/714,542
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,463,624: A Detailed Analysis

Introduction

Patent 10,463,624, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully comprehend this patent, it is crucial to delve into its various components and the broader patent landscape.

The Patent System in the United States

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The patent system is designed to encourage innovation by providing inventors with exclusive rights to their inventions for a specified period[2].

Patent 10,463,624 Overview

To analyze Patent 10,463,624, one must start by identifying the invention it describes. Here are the key elements:

Invention Description

The patent describes an invention related to a specific technological field. For example, if it pertains to AI, it might involve an artificial neural network designed to identify or detect anomalies, similar to the examples provided in the 2024 USPTO guidance update on AI patents[1].

Claims

The claims section is the most critical part of a patent, as it defines the scope of the invention and what is protected. Claims can be independent or dependent and must be clear, concise, and fully supported by the description.

Independent Claims

These claims stand alone and define the invention without reference to other claims. They are typically broader and set the foundation for the dependent claims.

Dependent Claims

These claims refer back to and further limit the independent claims. They often add specific details or features to the invention.

Scope of Protection

The scope of protection is determined by the claims. It is essential to ensure that the claims are drafted to cover the invention's novel and non-obvious aspects while avoiding overly broad language that might lead to section 101 rejections.

Analyzing the Claims

Claim Construction

Claim construction involves interpreting the language of the claims to understand their meaning and scope. This process is crucial in determining patent infringement and validity.

Patent Eligibility

The 2024 USPTO guidance update on AI patents emphasizes the importance of evaluating whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

Practical Applications and Examples

Real-World Applications

To bolster the argument for patent eligibility, it is essential to demonstrate how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. For instance, if the patent involves a method for enhancing the accuracy of voice commands in hands-free environments using separated audio components in a real-time speech recognition system, this practical application would meet the criteria for patent eligibility[1].

Examples from the USPTO Guidance

The USPTO has introduced new examples specifically tailored to AI technologies. These examples, such as Example 48, illustrate how claims involving specific applications of AI can meet the eligibility criteria by demonstrating an improvement in computer technology or providing a practical application[1].

Patent Landscape and Recent Developments

Historical Context

Understanding the historical context of patents can provide insights into how patent law has evolved. For example, early U.S. patents, known as "X" patents, were issued prior to 1836 and can be found in historical records[4].

Recent Case Law and Guidance

The 2024 USPTO guidance update incorporates recent Federal Circuit decisions, offering up-to-date legal standards and interpretations particularly relevant for AI inventions. This integration helps promote consistency and clarity in the application of patent eligibility criteria, reflecting the latest judicial thinking[1].

Data and Research

Patent Claims Research Dataset

The USPTO provides datasets containing detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. These datasets can be used to analyze trends and patterns in patent claims, including those related to AI technologies[3].

Filing Administrative Claims for Patent Infringement

If Patent 10,463,624 is alleged to be infringed, the process for filing an administrative claim involves several steps:

Requirements for Filing a Claim

The claim must be in writing and include an allegation of infringement, a request for compensation, a citation of the patent or patents alleged to be infringed, and a sufficient designation of the alleged infringing item or process[5].

Key Takeaways

  • Clear and Concise Claims: Ensure that the claims are well-drafted to avoid ambiguity and section 101 rejections.
  • Practical Applications: Demonstrate how the invention provides concrete benefits or solves specific problems in the relevant field.
  • Integration with Judicial Exceptions: Assess whether the claim integrates a judicial exception into a practical application.
  • Recent Case Law and Guidance: Stay updated with the latest legal standards and interpretations, especially for AI inventions.
  • Historical and Data Analysis: Use historical records and datasets to understand trends and patterns in patent claims.

FAQs

Q: What is the significance of the 2024 USPTO guidance update on AI patents?

A: The update provides clarifications on the patent eligibility of AI-related inventions, including detailed examples and the integration of recent case law, to help practitioners evaluate and draft claims more effectively.

Q: How do you determine the scope of protection for a patent?

A: The scope of protection is determined by the claims, which must be clear, concise, and fully supported by the description. It is essential to ensure that the claims cover the novel and non-obvious aspects of the invention.

Q: What are the key elements to include when filing an administrative claim for patent infringement?

A: The claim must include an allegation of infringement, a request for compensation, a citation of the patent or patents alleged to be infringed, and a sufficient designation of the alleged infringing item or process.

Q: How does the USPTO's Patent Claims Research Dataset help in analyzing patent claims?

A: The dataset provides detailed information on claims from U.S. patents and applications, allowing for the analysis of trends and patterns in patent claims, which can be particularly useful for understanding AI-related inventions.

Q: Why is it important to demonstrate practical applications in AI-related patent claims?

A: Demonstrating practical applications helps to show that the abstract idea is transformed into a specific, practical application that provides clear benefits, thereby meeting the criteria for patent eligibility.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims Research Dataset - USPTO
  4. How to Search for an Historical U.S. Patent - NYPL Libguides
  5. Requirements for filing an administrative claim for patent infringement. - Acquisition.gov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,463,624

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 10,463,624

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2122700 ⤷  Try for Free
Austria 268595 ⤷  Try for Free
Canada 2355854 ⤷  Try for Free
Germany 69917937 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.